Neximmune Inc (NEXI)

Currency in USD
0.100
0.000(0.00%)
Delayed Data·
NEXI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
NEXI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.1000.100
52 wk Range
0.0991.340
Key Statistics
Prev. Close
-
Open
0.1
Day's Range
0.1-0.1
52 wk Range
0.099-1.34
Volume
-
Average Volume (3m)
283
1-Year Change
-92.37%
Book Value / Share
0.51
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NEXI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Neximmune Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Neximmune Inc Company Profile

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company’s product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It provides NEXI-004 which is in preclinical stage for EBV related diseases; and NEXI005 designs for patient with specific targets for solid tumors. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.

Compare NEXI to Peers and Sector

Metrics to compare
NEXI
Peers
Sector
Relationship
P/E Ratio
0.0x−4.0x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x2.0x2.6x
Price / LTM Sales
-9.9x3.2x
Upside (Analyst Target)
-198.8%42.0%
Fair Value Upside
Unlock11.7%6.6%Unlock

Earnings

Latest Release
Aug 07, 2024
EPS / Forecast
-1.69 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

NEXI Income Statement

FAQ

What Stock Exchange Does Neximmune Trade On?

Neximmune is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Neximmune?

The stock symbol for Neximmune is "NEXI."

What Is the Neximmune Market Cap?

As of today, Neximmune market cap is 139.47K.

What Is Neximmune's Earnings Per Share (TTM)?

The Neximmune EPS (TTM) is -17.39.

From a Technical Analysis Perspective, Is NEXI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Neximmune Stock Split?

Neximmune has split 1 times.

How Many Employees Does Neximmune Have?

Neximmune has 6 employees.

What is the current trading status of Neximmune (NEXI)?

As of 30 Jul 2025, Neximmune (NEXI) is trading at a price of 0.10, with a previous close of 0.00. The stock has fluctuated within a day range of 0.10 to 0.10, while its 52-week range spans from 0.10 to 1.34.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.